Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.

Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), Bethesda, MD 20892-0520, USA.
Science (Impact Factor: 31.48). 02/2005; 307(5707):262-5. DOI: 10.1126/science.1105850
Source: PubMed

ABSTRACT Amyloid fibrils commonly exhibit multiple distinct morphologies in electron microscope and atomic force microscope images, often within a single image field. By using electron microscopy and solid-state nuclear magnetic resonance measurements on fibrils formed by the 40-residue beta-amyloid peptide of Alzheimer's disease (Abeta(1-40)), we show that different fibril morphologies have different underlying molecular structures, that the predominant structure can be controlled by subtle variations in fibril growth conditions, and that both morphology and molecular structure are self-propagating when fibrils grow from preformed seeds. Different Abeta(1-40) fibril morphologies also have significantly different toxicities in neuronal cell cultures. These results have implications for the mechanism of amyloid formation, the phenomenon of strains in prion diseases, the role of amyloid fibrils in amyloid diseases, and the development of amyloid-based nano-materials.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent findings have shown that several misfolded proteins can transmit disease pathogenesis in a prion-like manner by transferring their conformational properties to normally folded units. However, the extent by which these molecule-to-molecule or cell-to-cell spreading processes reflect the entire prion behavior is now subject of controversy, especially due to the lack of epidemiological data supporting inter-individual transmission of non-prion protein misfolding diseases. Nevertheless, extensive research has shown that several of the typical characteristics of prions can be observed for Aβ and tau aggregates when administered in animal models. In this article we review recent studies describing the prion-like features of both proteins, highlighting the similarities with bona fide prions in terms of inter-individual transmission, their strain-like conformational diversity, and the transmission of misfolded aggregates by different routes of administration. Copyright © 2015. Published by Elsevier B.V.
    Virus Research 01/2015; DOI:10.1016/j.virusres.2014.12.031 · 2.83 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The "Arctic" point mutation of the Alzheimer's amyloid beta-peptide is a rare mutation leading to an early onset of Alzheimer's disease. The peptide may interact with neuronal membranes, where it can provide its toxic effects. We used 2D NMR spectroscopy to investigate the conformation of the "Arctic" mutant of A beta 1-40 Alzheimer's amyloid peptide in sodium dodecyl sulfate micelle solutions, which are the type of amphiphilic structures mimicking some properties of biomembranes. The study showed that the Arctic mutant of A beta 1-40 interacts with the surface of SDS micelles mainly through the Leu17-Asn27 3(10)-helical region, while the Ile31-Val40 region is buried in the hydrophobic interior of the micelle. In contrast, wildtype A beta 1-40 interacts with SDS micelles through the Lys16-Asp23 alpha-helical region and Gly29-Met35. Both the Arctic mutant and the wild-type A beta 1-40 peptides interactions with SDS micelles are hydrophobic in nature. A beta peptides are thought to be capable of forming pores in biomembranes that can cause changes in neuronal and endothelial cell membrane permeability. It has also been shown that A beta peptides containing the "Arctic" mutation are more neurotoxic and aggregate more readily than the wildtype A beta peptides at physiological conditions. Here, we propose that the extension of the helical structure of Leu17-Asn27 and a high aliphaticity (neutrality) of the C-terminal region in the Arctic A beta peptides are consistent with the idea that formation of ion-permeable pores by A beta oligomers may be one of prevailing mechanisms of a larger neuronal toxicity of the Arctic A beta compared to the wild-type A beta peptides, independent of oxidative damage and lipid peroxidation.
    Journal of Molecular Structure 11/2014; 1076:518-523. DOI:10.1016/j.molstruc.2014.08.030 · 1.60 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Experimental evidence in animal models suggests that misfolded Amyloid-b (Ab) spreads in disease following a prion-like mechanism. Several properties characteristics of infectious prions have been shown for the induction of Ab aggregates. However, a detailed titration of Ab misfolding transmissibility and estimation of the minimum concentration of biologically active Ab seeds able to accelerate pathological changes has not yet been performed. In this study, brain extracts from old tg2576 animals were serially diluted and intra-cerebrally injected into young subjects from the same transgenic line. Animals were sacrificed several months after treatment and brain slices were analyzed for amyloid pathology. We observed that administration of misfolded Ab was able to significantly accelerate amyloid deposition in young mice, even when the original sample was diluted a million times. The titration curve obtained in this experiment was compared to the natural Ab load spontaneously accumulated by these mice overtime. Our findings suggest that administration of the largest dose of Ab seeds led to an acceleration of pathology equivalent to over a year. These results show that active Ab seeds present in the brain can seed amyloidosis in a titratable manner, similarly as observed for infectious prions.
    Scientific Reports 03/2015; 5. DOI:10.1038/srep09349 · 5.08 Impact Factor

Full-text (3 Sources)

Available from
May 27, 2014